AIM ImmunoTech announced the promotion of Christopher McAleer, Ph.D., from Deputy Scientific Officer to Scientific Officer.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on AIM:
- AIM ImmunoTech Appoints Christopher McAleer, Ph.D. as Scientific Officer
- AIM ImmunoTech Reports Positive Safety, Tolerability and Biological Activity Data for Intranasal Ampligen® (Rintatolimod) in Healthy Subjects
- AIM ImmunoTech reports safety, tolerability, biological data for Ampligen
- AIM ImmunoTech Announces Abstract Accepted for Poster Presentation at the British Society for Immunology Congress 2022
- AIM ImmunoTech Reports Third Quarter 2022 Financial Results and Provides Corporate Update